Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Accepted Abstracts: J Mol Biomark Diagn
Dr. Baolin Zhang is a Senior Investigator and a Drug Quality Reviewer at the Division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA). He is responsible for the quality review (Chemistry, Manufacturing and Control) for new therapeutic proteins under investigational new drug applications (INDs) and biologic license applications (BLAs). He also leads a research team in the conduct of FDA mission-related research improving drug safety and efficacy. His field of expertise lies in protein biochemistry, cell growth and death signaling, and cancer drug development, as evidenced by over 60 peer-reviewed articles. He serves as an Editorial Board member or reviewer for numerous peer-reviewed journals. Prior to joining FDA in 2001, he was a Senior Research Scientist at University of Tennessee, College of Medicine. He had also served as Professor and Deputy Director at the Beijing Center for Biologics Development and Research, and Associate Professor at Nanjing University. He earned his Ph.D. in chemistry from Peking University in 1992. He has received many awards including the 2010 FDA/CDER Scientific Achievement Awards for Excellence in Laboratory Science and the 2011 FDA/ CDER Leadership Excellence.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals